Aug. 25, 2005 — The U.S. Food and Drug Administration (FDA) has approved once-daily perindopril erbumine tablets for use alone or in combination with concurrent therapy to reduce the risk of ...

Continuing a trend in secondary prevention, the FDA has approved perindopril for the treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality and ...

Marietta, GA and Palo Alto, CA - The Food and Drug Administration yesterday approved a new indication for the ACE inhibitor perindopril (Aceon, Solvay Pharmaceuticals Inc and CV Therapeutics Inc) on ...

The Perindopril in Elderly People with Chronic Heart Failure study failed to show that perindopril could reduce long-term mortality or morbidity among elderly people with diastolic with heart failure.

Solvay Pharmaceuticals and partner CV Therapeutics have won a US Food and Drug Administration nod to expand the labelling for their heart drug Aceon (perindopril erbumine). The drug’s use will now be ...

The FDA approved a wider label for Aceon (perindopril erbumine), a cardiovascular drug marketed in part by CV Therapeutics Inc. through a partnership that has laid the groundwork for eventual sales of ...

Learn everything you need to know about Perindopril-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

BERKELEY, Calif., July 3, 2013 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today it has transferred U.S.